Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Micrus Endovascular Corp (MEND) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Micrus Endovascular Corp. Table 2 shows the detailed insider transactions. This company's CIK number is 1028318.
Total stock buying since 2010: $0.
Total stock sales since 2010: $125.
Total stock option exercises since 2010: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2010 | 0 | $0 | 7 | $125 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2010-05 | 0 | $0 | 7 | $125 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-05-17 | Bruguera Carolyn M (Vice Pres. & General Counsel) | Sale | 7 | 17.89 | 125 |
Insider trading activities including stock purchases, stock sales, and option exercises of MEND listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Micrus Endovascular Corp (symbol MEND, CIK number 1028318) see the Securities and Exchange Commission (SEC) website.